8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)
Published . Updated .
Filed: 2026-10-15 AccNo: 0001601830-26-000128 Size: 8 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- RXRX Recursion Pharmaceuticals
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-15 AccNo: 0001601830-26-000128 Size: 8 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01:…
Source: sec-edgar
The price since 15 Oct 2026: Recursion Pharmaceuticals (RXRX) versus the S&P 500
Since the first closing price after “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Recursion Pharmaceuticals (RXRX) is +4.34%. The S&P 500 fund (SPY) is +0.43% over the same days, a +3.91% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +1.78% | final price |
| GLD | the next day | +1.61% | final price |
| GLD | two days later | +0.98% | final price |
| GLD | three days later | +0.61% | still updating |
| GLD | three days earlier | +1.65% | final price |
| GLD | five days earlier | +0.71% | final price |
| QQQ | that day | -0.11% | final price |
| QQQ | the next day | -2.63% | final price |
| QQQ | two days later | -1.46% | final price |
| QQQ | three days later | -1.78% | still updating |
| QQQ | three days earlier | +2.33% | final price |
| QQQ | five days earlier | +2.54% | final price |
| Recursion Pharmaceuticals (RXRX) | that day | +11.11% | final price |
| Recursion Pharmaceuticals (RXRX) | the next day | -7.36% | final price |
| Recursion Pharmaceuticals (RXRX) | two days later | -3.48% | final price |
| Recursion Pharmaceuticals (RXRX) | three days later | -4.82% | still updating |
| Recursion Pharmaceuticals (RXRX) | three days earlier | +7.23% | final price |
| Recursion Pharmaceuticals (RXRX) | five days earlier | +5.49% | final price |
| SPY | that day | +0.28% | final price |
| SPY | the next day | -0.82% | final price |
| SPY | two days later | -0.40% | final price |
| SPY | three days later | -0.22% | still updating |
| SPY | three days earlier | +1.09% | final price |
| SPY | five days earlier | +0.55% | final price |
| TLT | that day | +1.41% | final price |
| TLT | the next day | +1.46% | final price |
| TLT | two days later | +0.74% | final price |
| TLT | three days later | +1.57% | still updating |
| TLT | three days earlier | -1.08% | final price |
| TLT | five days earlier | -1.29% | final price |
Who gains and who loses around Recursion Pharmaceuticals (RXRX)
Companies carried with this story
- RXRX Recursion Pharmaceuticals
In “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” Recursion Pharmaceuticals (RXRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> RXRX
How “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” reaches Recursion Pharmaceuticals (RXRX)
Recursion Pharmaceuticals (RXRX) is the company in “8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer),” the 15 Oct 2026 this story story.
What ties Recursion Pharmaceuticals (RXRX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> RXRX
Dates in the story, and the Recursion Pharmaceuticals (RXRX) price range
RXRX traded between 3.19 and 4.41 across 5 sessions. The latest close on file is 3.61.
A simple score for Recursion Pharmaceuticals (RXRX)
44 out of 100Price not final
“8-K - RECURSION PHARMACEUTICALS, INC. (0001601830) (Filer)” scores 44 out of 100. The score uses 1 sources, a -6.54% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.